Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Ketamine and its two enantiomers in anesthesiology and psychiatry: A historical review and future directions
Kenji Hashimoto, Mingming Zhao, Tingting Zhu, et al.
Journal of Anesthesia and Translational Medicine (2024) Vol. 3, Iss. 3, pp. 65-75
Open Access | Times Cited: 10

Showing 10 citing articles:

Transforming growth factor-β1 mediates the beneficial effects of arketamine on demyelination and remyelination in the brains of cuprizone-treated mice
Mingming Zhao, Tingting Zhu, Dan Xu, et al.
European Journal of Pharmacology (2024) Vol. 985, pp. 177096-177096
Open Access | Times Cited: 6
Special Issue on “Ketamine, MDMA, and Psychedelics in the Treatment of Neuropsychiatric Disorders”
Kenji Hashimoto, Xingming Wang, Jichun Zhang
Asian Journal of Psychiatry (2025) Vol. 106, pp. 104426-104426
Closed Access
The vagus nerve: An old but new player in brain–body communication
Li Ma, Hanbing Wang, Kenji Hashimoto
Brain Behavior and Immunity (2024)
Open Access | Times Cited: 4
Repeated administration of esketamine ameliorates mechanical allodynia in mice with chemotherapy-induced peripheral neuropathy: A role of gut microbiota and metabolites
Wei-Wei Luan, Hanwen Gu, Di Qiu, et al.
Neurochemistry International (2025) Vol. 185, pp. 105961-105961
Closed Access
Monoamine neurotransmitter-related gene-based genome-wide association study of low-dose ketamine in patients with treatment-resistant depression
Chung‐Feng Kao, Shih‐Jen Tsai, Tung‐Ping Su, et al.
Journal of Psychopharmacology (2025)
Closed Access
Effect of intravenous esketamine in emergency cesarean deliveries: a retrospective analysis of maternal and neonatal outcomes
Xiao-Mei Huang, Hongxia Qiu
The Journal of Maternal-Fetal & Neonatal Medicine (2024) Vol. 37, Iss. 1
Open Access
Ketamine attenuates kidney damage and depression-like behaviors in mice with cisplatin-induced acute kidney injury
Tianwen Huang, Yangyang He, Ruijuan Cheng, et al.
Translational Psychiatry (2024) Vol. 14, Iss. 1
Open Access
Splenic γδ T cells mediate antidepressant and prophylactic actions of arketamine in lipopolysaccharide-induced depression in mice
Guilin Liu, Li Ma, Akemi Sakamoto, et al.
Pharmacology Biochemistry and Behavior (2024) Vol. 245, pp. 173906-173906
Open Access
The role of ketamine and its enantiomer in managing depression and pain in cancer patients: A narrative review
Michael S. Bodnar, Sally Barber, Heather Jim, et al.
Journal of Anesthesia and Translational Medicine (2024) Vol. 3, Iss. 4, pp. 155-165
Open Access
Arketamine: a scoping review of its use in humans
Gustavo C. Leal, Isabel Lima-Araújo, David G. Roiter, et al.
European Archives of Psychiatry and Clinical Neuroscience (2024)
Closed Access
Arketamine alleviates cognitive impairments and demyelination in mice with postoperative cognitive dysfunction via TGF-β1 activation
Tingting Zhu, Mingming Zhao, Dan Xu, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2024) Vol. 136, pp. 111228-111228
Open Access
Page 1

Scroll to top